PODD Jul 2025 170.000 call
| Previous close | 40.00 |
| Open | 40.00 |
| Bid | 53.00 |
| Ask | 59.90 |
| Strike | 170.00 |
| Expiry date | 2025-07-18 |
| Day's range | 40.00 - 40.00 |
| Contract range | N/A |
| Volume | |
| Open interest | 2 |
Insider MonkeyInsulet (PODD) Faces Increasing Competition
ClearBridge Investments, an investment management company, released its “ClearBridge Select Strategy” first quarter 2024 investor letter. A copy of the letter can be downloaded here. The positive momentum in 2023 continued in the first quarter of 2024, the stocks surged on the expectation of a soft landing of the economy and a slowdown in rate […]
ZacksInsulet (PODD) Unveils Key Achievements for the Omnipod 5 System
Insulet (PODD) debuts the Omnipod 5 AID system in France and announces new updates for the U.S. markets.
Business WireInsulet Announces Full Commercial Launch of Omnipod 5 with Expanded Sensor Integrations in the United Kingdom and the Netherlands
ACTON, Mass., June 20, 2024--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced that Omnipod 5, compatible with both Dexcom G6 and Abbott FreeStyle Libre 2 Plus continuous glucose monitor (CGM) sensors, is now fully available in the U.K. and the Netherlands for individuals aged two years and older with type 1 diabetes. Omnipod 5 is the first and only tubeless automated insulin del
